Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jaad.2010.09.718 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Background: Bullous pemphigoid (BP) is a rare autoimmune blistering disease predominantly affecting the elderly population.
Objectives: The present study aims to identify clinical factors that may influence outcomes of BP, including skin phenotype, serology, mucosal involvement, pruritus, and triggers.
Methods: A retrospective analysis was conducted on 70 cases with BP registered from January 2019 to December 2022.
Nonbullous pemphigoid mimicking arthropod bite reactions in a patient with previously controlled classic bullous pemphigoid.
JAAD Case Rep
February 2024
University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina.
Approach to red, scaly eruptions in the older patient.
Aust J Gen Pract
December 2023
MBBS (Hons), MPhil, FACD, Consultant Dermatologist, Dermatology Department, Northern Hospital, Melbourne, Vic; Consultant Dermatologist, Preston Dermatology and Specialist Centre, Melbourne, Vic.
Background: Older patients with a red scaly eruption often present first to a primary care practitioner. A thorough clinical assessment can help delineate between common causes and assist the clinician with the next steps in management.
Objective: This article discusses the assessment of acute- to subacute-onset erythematous and scaly plaques that are present on multiple body sites in a patient aged >65 years.
Infiltration analysis of eosinophils and basophils and co-expression of CD69, CD63, IL-31 and IgE in patients with bullous and non-bullous pemphigoid.
J Eur Acad Dermatol Venereol
March 2024
Division of Experimental Allergy and Immunodermatology, University of Oldenburg, Oldenburg, Germany.
Bullous pemphigoid in a previously healthy adolescent: a case report and literature review.
Ann Med Surg (Lond)
October 2023
Internal Medicine Department, Beit-Jala Governmental Hospital, Bethlehem.
Introduction: Bullous pemphigoid (BP) is considered the most common bullous autoimmune disorder, characterized by autoantibodies directed against hemidesmosomes in the skin and mucous membranes. It usually affects elderly individuals in the sixth through eighth decades of life, with an average age at onset of 65 years. Only a few cases have been reported in children and teenagers.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!